About miraDry
miraDry is a Healthcare company based in Newport Beach (United States) founded in 2010, and was acquired by 1315 Capital in May 2021. Underarm sweat and odor glands are eliminated noninvasively. miraDry has raised $14.93 million across 3 funding rounds from investors including Sientra, Aisling Capital and Domain Associates. Its website miradry.com draws about 13 thousand monthly visits. Its focus areas include Life Sciences, Dermatology, Medical Devices and Therapeutic Devices. Its competitors include Zeno Corporation, Therative and ThermoTek; 2 of its 3 listed competitors have raised funding.
Company details
MiraDry was founded in 2010 and is based in Newport Beach, United States. The company operates in the medical device sector, focusing on noninvasive treatments for hyperhidrosis. The miraDry system, cleared by the FDA, is used to permanently reduce underarm sweat by targeting and eliminating sweat and odor glands. Local anesthesia is applied by healthcare providers prior to device use on marked areas.
- Headquarters Newport Beach, United States
- Stage Acquired
- SectorsHealthcare
- Email••••••••
- Website miradry.com
- Social LinkedIn X Facebook Instagram YouTube
- Acquired by 1315 Capital (May 2021)
- Total Equity Funding$14.93M (USD)
in 3 rounds
- Latest Funding Round$2.46M (USD), Series A
Feb 2017
- InvestorsSientra
& 6 more
- Acquired by
Apps and channels of miraDry
its YouTube channel miraDry has 583 subscribers and 4 videos.
Videos from miraDry
The most watched videos on miraDry's YouTube channel, miraDry (583 subscribers). Click a video to play it here.
More on miraDry.
Funding Insights of miraDry
miraDry has successfully raised a total of $14.93M across 3 strategic funding rounds. The most recent funding activity was a Series A round of $2.46 million completed in February 2017. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $14.93M
- Total Rounds 3
- Last Round Series A — $2.46M
- First Round $10M
(Feb 2014)
- Investors Count 5
All 3 funding rounds of miraDry with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Feb 2017 | $2.46M | Series A | – | – | – |
| Jan 2017 | $2.46M | Series D | – | – | – |
| Feb 2014 | $10M | Series D | – | – |
7 investors in total: 7 institutional.
Investors in miraDry
miraDry has secured backing from 7 investors, including venture fund investors. Prominent investors backing the company include Sientra, Aisling Capital and Domain Associates.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
PE firm investing in the US | aislingcapital.com | New York, United States | ||
Life science & tech focused VC firm investing in the US | domainvc.com | Princeton, United States | ||
Venture capital and private equity investment firm | morgenthaler.com | Portola Valley, United States | ||
Healthcare investments are managed by corporate-backed venture capital fund RusnanoMedInvest. | rmi.com.ru | Moscow, Russia | ||
Sector-agnostic investments in late-stage startups are made by Cross Creek. | crosscreek.vc | Salt Lake City, United States | ||
Expansion and growth capital is provided by 1315 Capital to healthcare companies. | 1315capital.com | Philadelphia, United States | ||
Products for plastic surgery and aesthetics are developed and marketed. | 2007 | sientra.com | Santa Barbara, United States |
Investor details for miraDry
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of miraDry
25 people are tracked at miraDry (13 in leadership, 12 in team).
| Name | Role | Group |
|---|---|---|
Jonathan Haiflich | Director Sales Operations | Leadership |
Jacklyn Van Hoef | Director of Distributor Sales Latin America | Leadership |
Irene Mo | VP of Quality & Regulatory | Leadership |
San Ly | Sr. Director, International Marketing (APAC, EU, MEA, LatAm) | Leadership |
Reggie Roeder | Director, Global Marketing | Leadership |
Jill Wassil | Chief Marketing Officer | Leadership |
Jason Simmons | Vice President of Sales | Leadership |
Rob Catlin | Chief Executive Officer | Leadership |
Trish Howell | Chief Operating Officer | Leadership |
Thomas Pongo | Sr. Director of Operations and Engineering | Leadership |
John Shortley | Chief Financial Officer | Leadership |
Kelly Holbin | Head Of Sales | Leadership |
Michelle O'Rourke | Associate Director of Sales- North America | Leadership |
Mark Probasco | Sales Operations Analyst | Team |
Evy Van Hoof | Business Development Manager | Team |
Mi Sol (Andy) Kim, CPA | Senior Manager, Accounting | Team |
Lan Le | Medical device manufacturing test technician lead | Team |
Raquel Redjai | Marketing Coordinator | Team |
Isabella Konofalski | Senior Accountant | Team |
Eugene Schantz | Strategic Business Manager | Team |
5 more people are available in the full profile.
Complete people profiles for miraDry
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of miraDry
5 dated milestones of miraDry across 11 years, from founding to its latest funding, stage changes and deals.
- Founded miraDry is founded.
- Funding First funding round of $10.0M.
- Funding Latest funding round, Series A, of $2.5M.
- Exit Acquired by Sientra.
- Exit Acquired by 1315 Capital.
Competitors of miraDry
miraDry has 3 listed competitors in our database, 2 of them funded. They include Zeno Corporation, Therative and ThermoTek.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| myzeno.com | 2002 | Houston, United States | $55M | Zeno Corporation develops devices for thermal treatment of acne. | ||
| therative.com | 2004 | San Francisco, United States | $9M | Technology news site covering innovations and industry reactions. | ||
| thermotekusa.com | 1998 | Dallas, United States | 59 | Thermoelectric, Thermal Management, and Medical Therapy Devices |
Detailed competitors of miraDry
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of miraDry
The website of miraDry (miradry.com) receives about 12.6K visits a month.
- Monthly visits12.6K
▼ 27.2% vs previous month
Websites whose visitors overlap most with miraDry. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
dermadry.com | dermadry.com | 100% | #513,624 | – | |
botoxseveresweating.com | botoxseveresweating.com | 98% | #4,887,340 | – | |
sweaty-palms.com | sweaty-palms.com | 89% | – | ||
| mycarpe.com | 89% | 1.2M | #51,439 | View details | |
| realself.com | 82% | 2.9M | #21,896 | View details | |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 18 similar websites and full traffic analytics for miraDry
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 18 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Top companies in Dermatology
3 companies that operate in the same segment as miraDry (Dermatology) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Neurotoxin products for aesthetic and therapeutic skin treatments are developed. | 2002 | Newark, New Jersey, United States | USD 154.56 M | USD 234.04 M | 597 | |
Diagnostic tests for cancer prognosis are provided. | 2008 | Friendswood, Texas, United States | USD 61.97 M | USD 344.23 M | 761 | |
Adhesive patch biopsies for skin cancer detection are provided. | 1996 | San Diego, California, United States | USD 24.37 M | USD 15.3 M | 259 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Miradry
Complete news archive for miraDry
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about miraDry
miraDry was founded in 2010 and raised its 1st funding round 4 years after it was founded.
miraDry is headquartered in Newport Beach, United States. It is registered at Newport Beach, California, United States.
miraDry is a funded company, having raised a total of $14.93M across 3 funding rounds to date. The company's 1st funding round was a Series D of $10M, raised on Feb 2014.
MiraDry was founded in 2010 and is based in Newport Beach, United States. The company operates in the medical device sector, focusing on noninvasive treatments for hyperhidrosis. The miraDry system, cleared by the FDA, is used to permanently reduce underarm sweat by targeting and eliminating sweat and odor glands. Local anesthesia is applied by healthcare providers prior to device use on marked areas.
miraDry's top competitors include ThermoTek, Zeno Corporation and Therative.
miraDry has 7 investors. Key investors include Sientra, Aisling Capital, Domain Associates, Morgenthaler, and RusnanoMedInvest.
Yes. miraDry was acquired by 1315 Capital in May 2021.